Truist Financial Lowers Aveanna Healthcare (NASDAQ:AVAH) Price Target to $5.25

Aveanna Healthcare (NASDAQ:AVAH) had its target price lowered by investment analysts at Truist Financial from $6.00 to $5.25 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Truist Financial’s price target suggests a potential upside of 17.98% from the stock’s current price.

Aveanna Healthcare Stock Performance

AVAH opened at $4.45 on Monday. The stock has a market capitalization of $859.85 million, a price-to-earnings ratio of -13.09 and a beta of 2.25. The company has a fifty day moving average of $5.13 and a 200 day moving average of $4.72. Aveanna Healthcare has a fifty-two week low of $2.00 and a fifty-two week high of $6.19.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $509.02 million for the quarter, compared to analysts’ expectations of $495.80 million. During the same quarter in the previous year, the business earned ($0.05) EPS. On average, equities research analysts forecast that Aveanna Healthcare will post -0.08 earnings per share for the current year.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently modified their holdings of the company. Geode Capital Management LLC grew its holdings in shares of Aveanna Healthcare by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock valued at $7,287,000 after purchasing an additional 63,190 shares in the last quarter. State Street Corp grew its stake in shares of Aveanna Healthcare by 0.9% in the 3rd quarter. State Street Corp now owns 1,039,920 shares of the company’s stock worth $5,408,000 after buying an additional 9,446 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Aveanna Healthcare by 3.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock worth $2,406,000 after buying an additional 17,522 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its position in shares of Aveanna Healthcare by 297.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock valued at $1,848,000 after buying an additional 265,969 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Aveanna Healthcare by 155.8% during the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock valued at $438,000 after buying an additional 96,600 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.